NDC 0019-0953
Conray
Iothalamate Meglumine
Conray is a Intravascular Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Iothalamate Meglumine.
| Product ID | 0019-0953_010a376a-cf48-4daa-9b83-a5b2264e3f3c |
| NDC | 0019-0953 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Conray |
| Generic Name | Iothalamate Meglumine |
| Dosage Form | Injection |
| Route of Administration | INTRAVASCULAR |
| Marketing Start Date | 2003-10-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA013295 |
| Labeler Name | Liebel-Flarsheim Company LLC |
| Substance Name | IOTHALAMATE MEGLUMINE |
| Active Ingredient Strength | 600 mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 0019-0953-05
25 VIAL, GLASS in 1 BOX (0019-0953-05) > 50 mL in 1 VIAL, GLASS
| Marketing Start Date | 2003-10-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0019-0953-50 [00019095350]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
NDC 0019-0953-03 [00019095303]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-10-14 |
| Marketing End Date | 2019-10-31 |
NDC 0019-0953-23 [00019095323]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
NDC 0019-0953-10 [00019095310]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-10-14 |
NDC 0019-0953-13 [00019095313]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
| Marketing End Date | 2019-10-31 |
NDC 0019-0953-11 [00019095311]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
| Marketing End Date | 2019-10-31 |
NDC 0019-0953-05 [00019095305]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
NDC 0019-0953-09 [00019095309]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
| Marketing End Date | 2019-10-31 |
NDC 0019-0953-15 [00019095315]
Conray INJECTION
| Marketing Category | NDA |
| Application Number | NDA013295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-14 |
| Marketing End Date | 2019-10-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| IOTHALAMATE MEGLUMINE | 600 mg/mL |
OpenFDA Data
| SPL SET ID: | 1292abfc-496f-4df7-9a08-72072953e1f1 |
| Manufacturer | |
| UNII | |
| UPC Code |
Pharmacological Class
- Radiographic Contrast Agent [EPC]
- X-Ray Contrast Activity [MoA]
NDC Crossover Matching brand name "Conray" or generic name "Iothalamate Meglumine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0019-0953 | Conray | iothalamate meglumine |
| 0019-3183 | Conray 43 | iothalamate meglumine |
| 0019-0862 | Cysto-Conray II | Iothalamate meglumine |
Trademark Results [Conray]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CONRAY 72128071 0737390 Live/Registered |
MALLINCKRODT CHEMICAL WORKS 1961-09-18 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.